Core Viewpoint - The company is focusing on expanding its production capacity and product line through innovation and strategic investments, particularly in the rehabilitation medical device sector [1][2][4]. Group 1: Investment and Expansion - The company is investing 400 million yuan in a new smart manufacturing base in Chengdu, expected to be completed by August this year, aimed at increasing production capacity and improving efficiency [1]. - The company has obtained 19 medical device registration certificates, covering various fields such as electrotherapy, oxygen therapy, and biofeedback [2]. Group 2: Product Development and Innovation - The company has launched several new products this year, including mid-frequency therapy devices and pelvic floor rehabilitation devices, which are essential for expanding market reach [1][2]. - The interference electric therapy device, a key product, has been developed with proprietary technology and patents, enhancing the company's competitiveness in the electrotherapy market [1]. - The company is also focusing on consumer health products, leveraging its expertise in professional medical devices to create innovative solutions for home use [3]. Group 3: Market Strategy - The company is actively expanding its overseas market presence, with products already reaching 70 countries, and plans to enhance its export efforts [4]. - The company recognizes the growing demand from the elderly population and is developing products tailored to their rehabilitation and health needs, such as portable oxygen machines and mid-frequency therapy devices [4].

Group 1: Investor Relations Activities - The company conducted a specific investor survey and media interviews on May 29, 2025, attended by representatives from Galaxy Securities, Rongxian Huijin Fund, and China Securities Journal [3][4] Group 2: Sales and Market Performance - The overseas market sales have remained stable this year, with the portable pneumatic massage system receiving widespread attention and positive feedback from global customers [4] - The company plans to enhance the market promotion of the compression boots, leveraging existing sales channels in the massage gun sector [4] Group 3: Product Innovation and Development - Future product innovation strategies include increased investment in "medical + consumer" resources and a focus on rehabilitation medical technology [5] - The company aims to develop more products suitable for the elderly, addressing the growing health needs of this demographic [5] Group 4: Profitability and Product Structure - The gross margin for rehabilitation medical products is 47.86%, while rehabilitation technology products have a gross margin of 37.11%, indicating room for improvement [6] - The company is actively developing new products to enrich its product line [6] Group 5: Investment Projects and Production Capacity - The Chengdu Intelligent Manufacturing Production Base is on track for completion, expected to be accepted in July 2025, which will enhance production capacity and efficiency [7] - The introduction of advanced production equipment and automated lines will lower production costs and improve overall profitability [7] Group 6: Research and Development - R&D expenses are determined by various factors, including company strategy and market demand, rather than a fixed threshold [9] - New products such as the medium-frequency therapy device and portable oxygen machine have received regulatory approval, while others are in development [9]